News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
Researchers have developed a new tool that could help clinicians diagnose the most common type of breast cancer more accurately and make better treatment decisions.
Scientists show that the immune system indirectly influences the genes that drive cancer
Researchers have uncovered new details about the complex relationship between the immune system and cancer.
Breast cancer risk model provides reassuring data for those with family history of disease after short-term HRT use
Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk model published in the British Journal of General Practice.
Neoadjuvant radiotherapy may hamper immunotherapy, new breast cancer research finds
A new study has provided novel insights into the effects of radiation on the immune cells surrounding breast cancer tumours.
Scientists create new way to predict bowel cancer risk in people with inflammatory bowel disease
Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer.
Uncovering the secrets of the secretome – underexplored cells near tumours may hold the answer to drug resistance
A new study has shown that non-cancerous cells positioned close to tumours can affect how cancer responds to treatment.
New method could improve the standard care of people with advanced cancer that has spread to the bones
Scientists have successfully used a form of artificial intelligence (AI) to develop a new imaging approach that makes it easier for radiologists to assess the extent of bone disease in people with advanced prostate cancer or multiple myeloma.
The future of ovarian cancer: innovation, treatment and hope
Ovarian cancer is often diagnosed late, making it difficult to treat. But innovative research at The Institute of Cancer Research, London, is changing how we think about managing this complex and hard-to-treat disease. Robbie Lockyer speaks to molecular pharmacology expert and medical oncologist Professor Udai Banerji to find out more about therapeutic research strategies.
ICR joins £10million AI project to help identify individual cancer risk
Doctors could soon be able to better predict an individual patient’s chances of getting cancer and offer them personalised detection and prevention strategies, thanks to a new research project co-led by scientists at The Institute of Cancer Research, London.
Innovative imaging study confirms feasibility of using smaller target areas in radiotherapy for early-stage glottic cancer
Scientists have successfully used real-time MRI to demonstrate that swallowing causes minimal motion of the larynx, known as the voice box, in people undergoing a radiotherapy session for cancer in this part of the body.
Genetic testing for Lynch Syndrome prevents cancers being missed
Genetic testing to identify women with Lynch Syndrome is likely to need to increase dramatically to ensure that carriers are not missed, a new analysis by ICR researchers has found.
MRI scanning and biopsy could reduce delays in the correct treatment for bladder cancer by more than six weeks
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time patients wait.
